Mingfeng Yu
Impact in
- Oncology top 5%
- Cancer-related Molecular Pathways
- Organic Chemistry top 5%
- Synthesis and biological activity
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 10
- Protein Degradation and Inhibitors 8
-
- Click Chemistry and Applications 6
- Synthesis and biological activity 5
- Quinazolinone synthesis and applications 4
- Co-authors
- Shudong Wang (34 shared papers)Malika Kumarasiri (11 shared papers)Theodosia Teo (17 shared papers)Sarah Diab (13 shared papers)Robert Milne (15 shared papers)Hugo Albrecht (14 shared papers)Solomon Tadesse (8 shared papers)Sunita K. C. Basnet (15 shared papers)
- Journals
- European Journal of Medicinal Chemistry (6 papers)Journal of Medicinal Chemistry (6 papers)Future Medicinal Chemistry (4 papers)ChemistryOpen (2 papers)ChemMedChem (2 papers)
- Partner nations
- AustraliaChinaUnited Kingdom
In The Last Decade
Mingfeng Yu
51 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 85
- Oncology 411
- Organic Chemistry 348
- Molecular Biology 657
- Pathology and Forensic Medicine 155
- Genetics 88
Countries citing papers authored by Mingfeng Yu
This map shows the geographic impact of Mingfeng Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingfeng Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingfeng Yu more than expected).
Fields of papers citing papers by Mingfeng Yu
This network shows the impact of papers produced by Mingfeng Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingfeng Yu. The network helps show where Mingfeng Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingfeng Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 121 | |
| 2 | 2017 | 82 | |
| 3 | 2014 | 80 | |
| 4 | 2014 | 71 | |
| 5 | 2017 | 63 | |
| 6 | 2020 | 61 | |
| 7 | 2016 | 60 | |
| 8 | 2015 | 44 | |
| 9 | 2019 | 43 | |
| 10 | 2016 | 41 | |
| 11 | 2014 | 38 | |
| 12 | 2011 | 33 | |
| 13 | 2017 | 32 | |
| 14 | 2015 | 31 | |
| 15 | 2014 | 31 | |
| 16 | 2015 | 29 | |
| 17 | 2022 | 28 | |
| 18 | 2015 | 27 | |
| 19 | 2017 | 24 | |
| 20 | 2015 | 23 |
About Mingfeng Yu
Mingfeng Yu is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 54 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (11 papers), PI3K/AKT/mTOR signaling in cancer (10 papers), Advanced Breast Cancer Therapies (10 papers), Cancer Mechanisms and Therapy (8 papers), Protein Degradation and Inhibitors (8 papers), Click Chemistry and Applications (6 papers), Synthesis and biological activity (5 papers) and Quinazolinone synthesis and applications (4 papers). The work is most often cited by research in Oncology (411 citations), Organic Chemistry (348 citations), Molecular Biology (657 citations), Pathology and Forensic Medicine (155 citations) and Genetics (88 citations). Mingfeng Yu has collaborated with scholars based in Australia, China and United Kingdom. Frequent co-authors include Shudong Wang, Malika Kumarasiri, Theodosia Teo, Sarah Diab, Robert Milne, Hugo Albrecht, Solomon Tadesse, Sunita K. C. Basnet, Matthew J. Sykes and Frankie Lam. Their work appears in journals such as European Journal of Medicinal Chemistry, Journal of Medicinal Chemistry, Future Medicinal Chemistry, ChemistryOpen and ChemMedChem.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.